Pure Monograph vs Citeline
Citeline sells pipeline and clinical intelligence data. Pure Monograph sells an AI authoring and intelligence platform. The overlap is narrow and sits on the intelligence-brief side — Citeline feeds data, Pure Monograph produces documents.
Short answer. Citeline (Norstella) is a data business: Pharmaprojects, Trialtrove, Scrip, Pink Sheet. Pure Monograph is an authoring and intelligence platform that covers CTD, tech transfer, CMC, and pipeline briefs. If you need curated pipeline data, buy Citeline. If you need to turn intelligence or CMC content into drafts and decisions, use Pure Monograph.
At a glance
| Dimension | Pure Monograph | Citeline (Norstella) |
|---|---|---|
| Primary deliverable | CTD drafts, tech transfer packages, BMRs, intelligence briefs | Pipeline, trial, and regulatory intelligence databases + editorial news |
| Category | AI authoring & analysis platform | Data + editorial subscriptions |
| Products / surfaces | 8 modules: CTD, Tech Transfer, Drug Design, Intelligence, News, Formulation Data Engine, Price Benchmark, BMR/Stability | Pharmaprojects (pipeline), Trialtrove (clinical trials), Scrip (news), Pink Sheet (regulatory news) |
| Regulatory output | Module 3 drafts, ICH / 21 CFR / USP aligned content | Not an authoring tool |
| Pricing | $0-$1,499 per month self-serve; $7,500-$80,000 USD request-based | Enterprise database subscriptions |
| Engagement model | Self-serve subscription + concierge | Multi-year data license |
| Ownership | Burrard Pharmaceutical Enterprises Ltd., Vancouver BC | Owned by Norstella (private equity portfolio) |
Where each wins
Citeline wins when you need an authoritative, continuously-curated view of competitor pipelines, clinical trial phases, or regulatory news as a data feed. Teams that maintain tracker dashboards, deal-flow models, or landscape monitoring are buying the data itself.
Pure Monograph wins when you need to do something with intelligence: brief an exec on competitor threat, draft an FDA AdCom summary, generate a pipeline section for a Module 3 narrative, or assemble a tech transfer package grounded in comparator-molecule analysis.
Using them together
Sponsors that license Citeline and use Pure Monograph typically feed Citeline exports or URLs into the Pure Monograph Intelligence module for synthesis. Pure Monograph does not ingest Citeline data without authorization; it produces original synthesis from explicit inputs or open data sources.
Frequently asked questions
What is Citeline?
Citeline is a Norstella-owned pipeline and clinical intelligence business covering Pharmaprojects, Trialtrove, Scrip, and Pink Sheet. It sells curated databases and editorial coverage.
Does Pure Monograph compete with Citeline?
Partly. Pure Monograph produces intelligence briefs that overlap with the questions Citeline data answers, but Pure Monograph is an AI authoring and analysis layer, not a curated database.
Can I use both?
Yes. Citeline is the source-of-truth data; Pure Monograph synthesizes intelligence into regulator-facing drafts, executive briefs, and CTD-adjacent content.
Do you license Citeline data?
No. Pure Monograph does not redistribute Citeline data. If you already license Citeline, Pure Monograph's briefs can be grounded against your own exports during engagement.